Oligonucleotide Synthesis Market size is poised to grow from USD 9.21 billion in 2024 to USD 34.86 billion by 2032, growing at a CAGR of 18.
Story Behind the Market – Oligonucleotide Synthesis
Genetic precision is unlocking a new era of diagnostics and therapeutics. The Oligonucleotide Synthesis Market is projected to grow from $9.21B in 2024 to $34.86B by 2032, at a powerful CAGR of 18.1%. This surge is fueled by the rise of gene therapies, personalized medicine, and PCR-based diagnostics—all demanding high-quality synthetic DNA and RNA sequences.
🚀 What’s driving the momentum?
🧬 Therapeutic expansion: antisense oligos, siRNA, and mRNA-based drugs for rare and chronic diseases
🧪 PCR primers & sequencing: essential tools for genetic testing and research
🤖 AI-powered synthesis: improving speed, purity, and scalability for clinical-grade oligos
With North America leading innovation and Asia-Pacific emerging as the fastest-growing region, oligonucleotide synthesis is becoming the backbone of precision medicine, biotech R&D, and next-gen diagnostics.
🔗 Read the full report: https://www.skyquestt.com/report/oligonucleotide-synthesis-market